METHOD OF TREATING RECURRENT GENITAL HERPES WITH CHRONIC FATIGUE SYMPTOMS Russian patent published in 2013 - IPC A61K31/452 A61K31/7105 A61P17/00 A61P31/22 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to dermatovenerology, and may be used for treating recurrent genital herpes with the chronic fatigue syndrome symptoms. That is ensured by administering an interferon inducer intramuscularly presented by high-polymer RNA in a dose of 8 mg every 72 hours for 10 days in a combination with oral administration of the antiviral drug Acyclovir 200 mg five times daily for 10 days. The other therapeutic regimen involves oral administration of the liposomal high-polymer RNA (Akaviya) daily 6.5 mg twice a day for 5 days, followed by the maintenance therapy in a dose of 6.5 mg every second day for 20 days and oral administration of Acyclovir 200 mg five times daily for 10 days.

EFFECT: method provides an effective treatment of the herpes infection and the disappearance of the symptoms that characterise chronic fatigue syndrome, due to the normalising the immune status: higher CD3+ and CD4+ lymphocyte count, higher blood ά and γ interferon, blood herpes virus elimination that promotes the general state recovery in the female patients.

9 tbl